Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 27;15(10):e47818.
doi: 10.7759/cureus.47818. eCollection 2023 Oct.

Outcome of Atrial Fibrillation Ablation in Cancer Patients: A Review

Affiliations
Review

Outcome of Atrial Fibrillation Ablation in Cancer Patients: A Review

Nava R Sharma et al. Cureus. .

Abstract

Atrial fibrillation (AF), a cardiac arrhythmia, exhibits a heightened prevalence among individuals diagnosed with cancer, notably prominent in cases of lung and gastrointestinal malignancies. Robust evidence from extensive studies underscores this association, emphasizing its clinical significance. However, the precise mechanistic underpinnings and specific risk factors linking cancer and AF remain a subject of incomplete understanding. Notably, the prevalence of AF in cancer patients substantially exceeds that in non-cancer counterparts, prompting further exploration of the underlying pathophysiological processes. This review aims to address the existing knowledge void regarding AF management in cancer patients, with a specific focus on the potential role of ablation procedures. While catheter and surgical ablation techniques have been thoroughly investigated and validated as effective treatments within non-cancer populations, their applicability and outcomes in cancer patients have remained inadequately explored. The principal objective of this exhaustive review is to bridge this research gap by conducting a meticulous examination of the feasibility, safety, and effectiveness of ablation interventions for AF in the context of cancer patients. By amalgamating existing evidence and pinpointing critical areas necessitating additional investigation, this review endeavors to provide invaluable insights into AF management in cancer patients, with the ultimate goal of enhancing their clinical care and optimizing outcomes.

Keywords: atrial fibrillation (af); atrial fibrillation and cancer; cancer patients; cardiac catheter ablation; radiofrequency catheter ablation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Schematic diagram of underlying mechanistic processes involved in the pathophysiology of AF in cancer patients.
AF: atrial fibrillation; IL: Interleukin; TNF-a: tumor necrosis factor-alpha; CRP: C-reactive protein; ANS: autonomic nervous system. Image credit: Dr. Arjun Basnet.

References

    1. Atrial fibrillation and risk of cancer: a Danish population-based cohort study. Vinter N, Christesen AM, Fenger-Grøn M, Tjønneland A, Frost L. J Am Heart Assoc. 2018;7:0. - PMC - PubMed
    1. Risk of atrial fibrillation according to cancer type: a nationwide population-based study. Yun JP, Choi EK, Han KD, et al. JACC CardioOncol. 2021;3:221–232. - PMC - PubMed
    1. Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study. Jakobsen CB, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason GH, Schou M. BMC Cancer. 2019;19:1105. - PMC - PubMed
    1. Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study. Ay C, Grilz E, Nopp S, et al. Res Pract Thromb Haemost. 2023;7:100026. - PMC - PubMed
    1. Atrial fibrillation in cancer patients: hindsight, insight and foresight. Mery B, Guichard JB, Guy JB, et al. Int J Cardiol. 2017;240:196–202. - PubMed

LinkOut - more resources